Biohope is a biomedical company that focuses on the research and development of precision medicine IVD tools for patients with chronic inflammatory conditions and autoimmune diseases. The company's unique and innovative product, Immunobiogram®, addresses a huge unmet medical need by providing the level of sensitivity of the patient's immune cells to immunosuppressive drugs in order to facilitate a personalized treatment to improve clinical outcomes. Biohope has successfully studied the Immunobiogram® for kidney transplantation in international clinical studies with main hospitals from Europe and USA and is prepared to launch its first product to the market. The company has a unique software and database of patient's T lymphocyte response, published patents, and a registered trademark in main markets. Its objective is to support physicians by providing them with tools to optimize and personalize treatments and thus improve the response and quality of life of patients.